These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11388221)

  • 1. Hemograft crossmatching is unnecessary due to the absence of blood group antigens.
    Kadner A; Chen RH; Mitchell RN; Adams DH
    Ann Thorac Surg; 2001 May; 71(5 Suppl):S349-52. PubMed ID: 11388221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Banking of cryopreserved heart valves in Europe: assessment of a 10-year operation in the European Homograft Bank (EHB).
    Goffin YA; Van Hoeck B; Jashari R; Soots G; Kalmar P
    J Heart Valve Dis; 2000 Mar; 9(2):207-14. PubMed ID: 10772038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of A and B blood group antigens on cryopreserved homografts.
    Feingold B; Wearden PD; Morell VO; Galvis D; Galambos C
    Ann Thorac Surg; 2009 Jan; 87(1):211-4. PubMed ID: 19101299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of ABH-antigen expression on human cardiac valves.
    Kadner A; Chen RH; Mitchell RN; Adams DH
    J Heart Valve Dis; 2000 Jul; 9(4):512-6. PubMed ID: 10947043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological aspects of fresh and cryopreserved aortic valve transplantation in rats.
    Oei FB; Stegmann AP; Vaessen LM; Marquet RL; Weimar W; Bogers AJ
    Ann Thorac Surg; 2001 May; 71(5 Suppl):S379-84. PubMed ID: 11388229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of immune stimulatory cells in fresh and cryopreserved donor aortic and pulmonary valve allografts.
    Oei FB; Stegmann AP; van der Ham F; Zondervan PE; Vaessen LM; Baan CC; Weimar W; Bogers AJ
    J Heart Valve Dis; 2002 May; 11(3):315-24; discussion 325. PubMed ID: 12056721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates of cycling cells in cryopreserved valvular homograft: a preliminary study.
    Barili F; Dainese L; Cheema FH; Dell'Antonio G; Topkara VK; Rossoni G; Guarino A; Micheli B; Doglioni C; Biglioli P; Polvani G
    Artif Organs; 2007 Feb; 31(2):152-4. PubMed ID: 17298405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of HLA matching and associated factors on aortic valve homograft function.
    Dignan R; O'Brien M; Hogan P; Passage J; Stephens F; Thornton A; Harrocks S
    J Heart Valve Dis; 2000 Jul; 9(4):504-11. PubMed ID: 10947042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryopreserved semilunar heart valve allografts: leaflet surface damage in scanning electron microscopy.
    Burkert J; Krs O; Vojácek J; Mokrácek A; Slízová D; Hlubocký J; Kobylka P; Spatenka J
    Zentralbl Chir; 2008 Aug; 133(4):367-73. PubMed ID: 18702023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA expression in aortic and pulmonary homografts: effects of cryopreservation.
    Verghese S; Cherian KM
    Indian Heart J; 2002; 54(4):394-8. PubMed ID: 12462667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrity and viability of homograft valves.
    Fischlein T; Schütz A; Uhlig A; Frey R; Krupa W; Babic R; Thiery J; Reichart B
    Eur J Cardiothorac Surg; 1994; 8(8):425-30. PubMed ID: 7986560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining viability of fresh or cryopreserved homograft valves at implantation.
    Gonzalez-Lavin L; McGrath LB; Amini S; Graf D
    Heart Vessels; 1987; 3(4):205-8. PubMed ID: 3453826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Banking cryopreserved heart valves in Europe: assessment of a 5-year operation in an international tissue bank in Brussels.
    Goffin Y; Grandmougin D; Van Hoeck B
    Eur J Cardiothorac Surg; 1996; 10(7):505-12. PubMed ID: 8855421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitral valve surgery utilizing homografts: early results.
    Gulbins H; Kreuzer E; Uhlig A; Reichart B
    J Heart Valve Dis; 2000 Mar; 9(2):222-9. PubMed ID: 10772040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cytotoxic T lymphocytes with destructive potential after cardiac valve homograft implantation.
    Oei FBS ; Welters MJ; Vaessen LM; Stegmann AP; Bogers AJ; Weimar W
    J Heart Valve Dis; 2000 Nov; 9(6):761-8. PubMed ID: 11128781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Explanted cryopreserved allografts: a morphological and immunohistochemical comparison between arterial allografts and allograft heart valves from infants and adults.
    Vogt PR; Stallmach T; Niederhäuser U; Schneider J; Zünd G; Lachat M; Künzli A; Turina MI
    Eur J Cardiothorac Surg; 1999 May; 15(5):639-44; discussion 644-5. PubMed ID: 10386410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iranian homograft heart valves: assessment of durability and late outcome.
    Heidary Rouchi A; Radmehr H; Tavakoli SA; Jafarzadeh Kashi TS; Mahdavi-Mazdeh M
    Cell Tissue Bank; 2016 Dec; 17(4):603-610. PubMed ID: 27501816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for rejection of homograft cardiac valves in infants.
    Rajani B; Mee RB; Ratliff NB
    J Thorac Cardiovasc Surg; 1998 Jan; 115(1):111-7. PubMed ID: 9451053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of homografts in clinical surgery.
    Ross D
    J Card Surg; 1987 Mar; 2(1 Suppl):175-83. PubMed ID: 2979969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of structural valve failure among different 'models' of homograft valves.
    Grunkemeier GL; Bodnar E
    J Heart Valve Dis; 1994 Sep; 3(5):556-60. PubMed ID: 8000592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.